Michael F. Chang

957 total citations
32 papers, 678 citations indexed

About

Michael F. Chang is a scholar working on Hepatology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael F. Chang has authored 32 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 14 papers in Epidemiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael F. Chang's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (11 papers) and Hepatitis C virus research (5 papers). Michael F. Chang is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (11 papers) and Hepatitis C virus research (5 papers). Michael F. Chang collaborates with scholars based in United States, Denmark and Vietnam. Michael F. Chang's co-authors include Lauren A. Beste, George N. Ioannou, Kristin Berry, Pamela K. Green, Jason A. Dominitz, David B. Ross, Elliott Lowy, Feng Su, Judith I. Tsui and Yin Yang and has published in prestigious journals such as Gastroenterology, Hepatology and Diabetes Care.

In The Last Decade

Michael F. Chang

25 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael F. Chang United States 12 470 459 68 67 39 32 678
Danielle Roberts United Kingdom 12 90 0.2× 118 0.3× 22 0.3× 36 0.5× 19 0.5× 33 370
Mikako Obika Japan 10 177 0.4× 305 0.7× 62 0.9× 92 1.4× 38 1.0× 54 663
Jiamin Yin Hong Kong 11 53 0.1× 263 0.6× 94 1.4× 46 0.7× 14 0.4× 18 620
Hatice Keleş Türkiye 13 101 0.2× 118 0.3× 16 0.2× 37 0.6× 8 0.2× 24 478
P Chou Taiwan 10 78 0.2× 146 0.3× 20 0.3× 46 0.7× 20 0.5× 19 414
Michael Armbrust United States 17 338 0.7× 167 0.4× 244 3.6× 11 0.2× 28 0.7× 39 1.0k
Zhan-Zhan Li China 8 59 0.1× 185 0.4× 21 0.3× 22 0.3× 35 0.9× 11 409
Xia Y China 14 24 0.1× 131 0.3× 79 1.2× 26 0.4× 8 0.2× 39 428
Salahuddin Afsar Pakistan 12 127 0.3× 180 0.4× 16 0.2× 19 0.3× 73 1.9× 34 411
Amina Nadeem Pakistan 12 43 0.1× 79 0.2× 17 0.3× 27 0.4× 10 0.3× 33 295

Countries citing papers authored by Michael F. Chang

Since Specialization
Citations

This map shows the geographic impact of Michael F. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Chang more than expected).

Fields of papers citing papers by Michael F. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Chang. The network helps show where Michael F. Chang may publish in the future.

Co-authorship network of co-authors of Michael F. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Chang. A scholar is included among the top collaborators of Michael F. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Chang. Michael F. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yakovchenko, Vera, Michael F. Chang, Rubén Hernáez, et al.. (2024). Access to Evaluation for Liver Transplantation in the Veterans Health Administration. Digestive Diseases and Sciences. 70(2). 552–565.
2.
Hansen, Lissi, Michael F. Chang, Shirin O. Hiatt, Nathan F. Dieckmann, & Christopher S. Lee. (2024). Informal Family Care Partner Well-Being Is Diminished in End-Stage Liver Disease. Nursing Research. 73(4). E202–E211.
3.
Hansen, Lissi, Michael F. Chang, Shirin O. Hiatt, Nathan F. Dieckmann, & Christopher S. Lee. (2024). Distinct Longitudinal Trajectories of Symptom Burden Predict Clinical Outcomes in End-Stage Liver Disease. Clinical and Translational Gastroenterology. 15(8). e00728–e00728.
4.
Chang, Michael F. & Martin Sedláček. (2023). An Unusual Cause of Cloudy Urine in a Patient with Sepsis. Journal of the American Society of Nephrology. 34(11S). 109–109.
5.
Adejumo, Adeyinka, Vera Yakovchenko, Timothy R. Morgan, et al.. (2023). The road to pandemic recovery: Tracking COVID-19’s impact on cirrhosis care and outcomes among 111,558 Veterans. Hepatology. 77(6). 2016–2029. 2 indexed citations
6.
Borgerding, Joleen, et al.. (2022). Participant Characteristics and Attendance Patterns for a Multispecialty Veterans Affairs ECHO Program 2012–2018. Telemedicine Journal and e-Health. 28(11). 1633–1641. 2 indexed citations
7.
Hansen, Lissi, Michael F. Chang, Shirin O. Hiatt, et al.. (2021). Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis. Digestive Diseases and Sciences. 67(8). 4234–4242. 10 indexed citations
8.
Hansen, Lissi, Michael F. Chang, Shirin O. Hiatt, et al.. (2021). Symptom Classes in Decompensated Liver Disease. Clinical Gastroenterology and Hepatology. 20(11). 2551–2557.e1. 4 indexed citations
9.
Cheng, Jerome, et al.. (2021). Transient elastography versus liver biopsy: discordance in evaluations for fibrosis and steatosis from a pathology standpoint. Modern Pathology. 34(10). 1955–1962. 15 indexed citations
10.
Hansen, Lissi, Michael F. Chang, Christopher S. Lee, et al.. (2020). Physical and Mental Quality of Life in Patients With End-Stage Liver Disease and Their Informal Caregivers. Clinical Gastroenterology and Hepatology. 19(1). 155–161.e1. 24 indexed citations
11.
Beste, Lauren A., Michael Icardi, Christine M. Hunt, et al.. (2019). Alanine Aminotransferase Results Differ by Analyzer Manufacturer in a National Integrated Health Setting, 2012–2017. Archives of Pathology & Laboratory Medicine. 144(6). 748–754. 2 indexed citations
12.
Beste, Lauren A., George N. Ioannou, Michael F. Chang, et al.. (2019). Prevalence of Hepatitis B Virus Exposure in the Veterans Health Administration and Association With Military-Related Risk Factors. Clinical Gastroenterology and Hepatology. 18(4). 954–962.e6. 3 indexed citations
13.
McCready, Holly, Milky Kohno, Laura E. Dennis, et al.. (2018). Functional MRI and delay discounting in patients infected with hepatitis C. Journal of NeuroVirology. 24(6). 738–751. 3 indexed citations
14.
Loftis, Jennifer M., Rebekah Hudson, Michael F. Chang, et al.. (2018). S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood–Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder. Alcoholism Clinical and Experimental Research. 42(8). 1466–1475. 13 indexed citations
15.
16.
Hansen, Lissi, Nathan F. Dieckmann, Kenneth J. Kolbeck, Willscott E. Naugler, & Michael F. Chang. (2017). Symptom Distress in Patients With Hepatocellular Carcinoma Toward the End of Life. Oncology nursing forum. 44(6). 665–673. 18 indexed citations
17.
Beste, Lauren A., Thomas J. Glorioso, P. Michael Ho, et al.. (2016). Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs. The American Journal of Medicine. 130(4). 432–438.e3. 76 indexed citations
18.
Loudin, Michael, et al.. (2015). Liver Failure Secondary to Amyloid Light-Chain Amyloidosis. The American Journal of Medicine. 129(4). e19–e20. 3 indexed citations
19.
Beste, Lauren A., George N. Ioannou, Yin Yang, et al.. (2014). Improved Surveillance for Hepatocellular Carcinoma With a Primary Care–Oriented Clinical Reminder. Clinical Gastroenterology and Hepatology. 13(1). 172–179. 94 indexed citations
20.
Lessig, Stephanie, Kiren Ubhi, Douglas Galasko, et al.. (2010). Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport. 21(11). 756–760. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danielle Roberts Breakdown of academic impact, for papers by Mikako Obika Breakdown of academic impact, for papers by Jiamin Yin Breakdown of academic impact, for papers by Hatice Keleş Breakdown of academic impact, for papers by P Chou Breakdown of academic impact, for papers by Michael Armbrust Breakdown of academic impact, for papers by Zhan-Zhan Li Breakdown of academic impact, for papers by Xia Y Breakdown of academic impact, for papers by Salahuddin Afsar Breakdown of academic impact, for papers by Amina Nadeem
Rankless by CCL
2026